What the show proves most of all is how successfully the marriage industrial complex has come for, and won over, the gays.

A study found that complete blood counts may be used to diagnose placental abruption, a risk factor for HDFN with no ...

With initial attraction, perceived qualities outperform actual qualities. Only one measured ability—women’s creativity—was ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

The real power of this blood test isn’t just in its convenience – it’s in the timing. Alzheimer’s changes begin happening in your brain years, sometimes decades, before you notice any ...

The Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test is designed for the early detection of amyloid plaques associated with Alzheimer’s disease in adults aged 55 years and older who are ...

No. The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

In clinical trials, the Lumipulse blood test was highly accurate at detecting brain plaques tied to Alzheimer’s disease, which paved the way for FDA approval. Compared to brain scans and spinal ...

The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's detection in adults aged 55 and older showing symptoms. It analyzes ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the memory ...

The agency says that Fujirebio submitted data from a study of 499 blood plasma samples of adults who had cognitive impairment, comparing the results from the blood test with the alternative ways ...

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.